Q Bio Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 34
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $12M
Latest Deal Amount
  • Investors
  • 10

Q Bio General Information

Description

Developer of a clinical digital twin platform designed to assess the medical history of patients in order to flag their immediate and future health risks. The company's platform performs whole-body scans to generate a digital twin of the patient's physical body to quantify, digitize, the data and utilize simulated human physiology and machine learning to predict potential health risks, enabling healthcare personnel to render proactive treatment to patients.

Contact Information

Website
www.q.bio
Formerly Known As
Tesla Health
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 410 Brewster Avenue
  • Redwood City, CA 94063
  • United States
+1 (415) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Q Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series B) $12M 0000 00000 Completed Startup
3. Later Stage VC (Series B) 20-Feb-2020 0000 0000 00000 Completed Startup
2. Early Stage VC (Series A) 01-Feb-2018 $11M $18M 0000 Completed Startup
1. Seed Round 29-Jan-2016 $7M $7M 0000 Completed Startup
To view Q Bio’s complete valuation and funding history, request access »

Q Bio Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series A 0,000,000 00.000000 00.0 00.00 00.00 00 00.00 00.000
Seed 6,763,471 $0.000010 $0.08 $1.03 $1.03 1x $1.03 10.71%
To view Q Bio’s complete cap table history, request access »

Q Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a clinical digital twin platform designed to assess the medical history of patients in order to flag their
Diagnostic Equipment
Redwood City, CA
34 As of 2021
0000
0000 0000-00-00
000000 0 0000

000000 0

re dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur
0000000000000 00000000
Oakland, CA
00 As of 0000
000.00
00000000000 000.00

000000

tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitati
00000 0000000000 0000000000 0000000
San Francisco, CA
000 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Q Bio Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Fabric Genomics Venture Capital-Backed Oakland, CA 00 000.00 00000000000 000.00
000000 Venture Capital-Backed San Francisco, CA 000 00000 000000 - 000 00000
000000 00000000 Formerly VC-backed Saint Sulpice, Switzerland 000 00000 000000000 00000
000000 0000 000000 Formerly VC-backed Bangalore, India 000 000.00 000000&0 000.00
000000000 Venture Capital-Backed Ann Arbor, MI 00 000.00 00000000000 000.00
You’re viewing 5 of 10 competitors. Get the full list »

Q Bio Patents

  • 36

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 9

    Granted

  • 6

    Pending

  • 000

    Expiring in next 12 mo

Q Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210311151-A1 Maxwell parallel imaging Pending 27-Sep-2019 00000000000
US-11131735-B2 Maxwell parallel imaging Active 27-Sep-2019 00000000000 00
US-20210096203-A1 Maxwell parallel imaging Granted 27-Sep-2019 00000000000
US-20200265328-A1 Model parameter determination using a predictive model Pending 15-Feb-2019 0000000000
US-20200264249-A1 Tensor field mapping with magnetostatic constraint Pending 15-Feb-2019 G01R33/5608
To view Q Bio’s complete patent history, request access »

Q Bio Executive Team (6)

Name Title Board Seat Contact Info
Jeffrey Kaditz Co-Founder, Chief Executive Officer & Chief Technology Officer
Clarissa Shen Chief Operating Officer and Board Member
Michael Snyder Ph.D Co-Founder
Garry Choy MD Co-Founder & Medical Director
You’re viewing 4 of 6 executive team members. Get the full list »

Q Bio Board Members (3)

Name Representing Role Since
Clarissa Shen Q Bio Chief Operating Officer and Board Member 000 0000
Vijay Pande Ph.D Andreessen Horowitz Board Member 000 0000
Vinod Khosla Khosla Ventures Board Member 000 0000
To view Q Bio’s complete board members history, request access »

Q Bio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Q Bio Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Expanding Capital Venture Capital Minority 000 0000 000000 0
SciFi VC Venture Capital Minority 000 0000 000000 0
Sea Lane Ventures Venture Capital Minority 000 0000 000000 0
Thirtyfive Ventures Venture Capital Minority 000 0000 000000 0
Andreessen Horowitz Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial